AUGUST 25 - 26
Ubiquitin-Induced Targeted Protein Degradation
Ubiquitin-Induced Protein Degradation
Fragment-Based Drug Discovery
Fragment-Based Drug Discovery
Kinase Inhibitor Chemistry
Kinase Inhibitor Chemistry
Macrocyclics & Constrained Peptides
Macrocyclics & Constrained Peptides
AUGUST 26 - 27
Protein-Protein Interactions
Protein-Protein Interactions
Artificial Intelligence for Early Drug Discovery
Artificial Intelligence for Early Drug Discovery
Small Molecules for Immunology & Oncology
Small Molecules for Immunology & Oncology
Encoded Libraries for Small Molecule Discovery
Encoded Libraries for Small Molecule Discovery
AUGUST 28
RNA as a Small Molecule Target
RNA as a Small Molecule Target
Biophysical Approaches for Drug Discovery
Biophysical Approaches
Lead Optimization for Drug Metabolism & Safety
Lead Optimization for Drug Metabolism



PLENARY KEYNOTES

Discovery of Bioactive, Passively Permeable Cyclic Peptides: Translating Theory into Practice

Scott Lokey, PhD
Professor, Chemistry and Biochemistry, University of California, Santa Cruz

Translational Chemistry

Phil Baran, PhD
Professor, Department of Chemistry, Scripps Research